Second Quarter 2026 Highlights:Liquid Assets1, ended Q2 2026 with $170.8 million, compared to $90.5 million in Q2 2025. Adjusted EBITDA1 of $15.7 million in Q2 2026, versus $28.9 million in Q2 2025; YTD 2026 Adjusted EBITDA of $86.6 million versus $50.8 million YTD 2025. Net cash used in operating activities, the most directly comparable IFRS measure, was $50.9 million for Q2 2026 (Q2 2025: $20.3 million provided). Golden Queen cost of sales, the most directly comparable IFRS measure, was $15.8 million for Q2 2026 (Q2 2025: $21.6 million). San Bartolome cost of sales, the most directly comparable IFRS measure, was $23.6 million for Q2 2026 (Q2 2025: $18.7 million).